Al-mutanabbe Drug Store and our principle SOOFT-Fidia, participated in the International Congress of the Middle East and Africa Council of Ophthalmology, jointly with the Jordanian Ophthalmology Conference.
With the participation of our partner SOFAR and Professor Elia Ricci as a speaker, the new and innovative product Sofargen Spray was launched in Jordan. The event was done over two days and saw significant attendance from surgeons, vascular surgeons, gynecologists and orthopedic surgeons.
Under the title “Differentiating and Targeting Dry Eye”, a webinar was presented by Italian Key Opinion Leaders, and attended in Jordan by a group of our ophthalmologists.
Inviting our doctors to the Southern City of Aqaba over 3 weekends for a series of stand-alone meetings talking about our unique ophthalmology range.
We participated in the first Jordanian Female Physician Congress held in Amman, on behalf of our principles Fidia, IBSA, General Topics and Sofar.
Launching of our unique Kidney Stone Disease products in Kuwait.
The 10 International JSOHNS Congress was held in participation with the 13th Pan Arab Rhinology Society Congress in Amman, Jordan
From the manufacturers of Hyaluronic Acid in Europe, IBSA, comes the unique filler Aliaxin. It was launched in Jordan in June 2022.
To launch our Devicare line in Jordan, we participated in the Urological Society Congress. Spanish Key Opinion Leader Dr. Alberto Budia was present in a symposium about Kidney stone treatment.
